Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Prudential Jennison Health Sciences Fund

+ Add to Watchlist

PHLCX:US

44.77 USD 0.76 1.73%

As of 09:29:30 ET on 03/27/2015.

Snapshot for Prudential Jennison Health Sciences Fund (PHLCX)

Year To Date: +13.51% 3-Month: +12.66% 3-Year: +36.03% 52-Week Range: 28.31 - 46.57
1-Month: +3.37% 1-Year: +44.19% 5-Year: +28.37% Beta vs SPR: 0.90

Mutual Fund Chart for PHLCX

No chart data available.
  • PHLCX:US 44.77
  • 1M
  • 1Y
Interactive PHLCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHLCX

Prudential Jennison Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of assets plus borrowings for investment purposes in securities of companies in the health sciences sector, such as pharmaceutical, biotechnology and healthcare service providers.

Inception Date: 06-30-1999 Telephone: 1-800-225-1852
Managers: DAVID CHAN / MICHAEL DEL BALSO
Web Site: www.prudentialfunds.com

Fundamentals for PHLCX

NAV (on 2015-03-27) 44.77
Assets (M) (on 2015-03-27) 3,595.06
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 100.00

Dividends for PHLCX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-23) 1.84
Dividend Yield (ttm) 15.44

Fees & Expenses for PHLCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.72
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 1.85

Top Fund Holdings for PHLCX

Filing Date: 01/31/2015
Name Position Value % of Total
BioMarin Pharmaceutical Inc 1,752,708 170,293,109 5.359%
Incyte Corp 1,607,959 128,170,412 4.034%
Shire PLC 581,006 127,391,376 4.009%
Celgene Corp 923,254 110,014,947 3.462%
Biogen Inc 275,374 107,164,546 3.372%
Medtronic PLC 1,464,260 104,548,183 3.290%
Pacira Pharmaceuticals Inc/DE 816,450 87,645,908 2.758%
AstraZeneca PLC 1,150,144 81,706,230 2.571%
Illumina Inc 413,882 80,785,628 2.542%
Intercept Pharmaceuticals Inc 383,706 77,136,417 2.427%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil